article thumbnail

The Imperative for KAM in Pharma

PM360

Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated key account management (KAM) strategies and capabilities to provide unique offerings and value. How should leading pharma companies respond? The Importance of Large, Organized Customers.

article thumbnail

Largest global clinical site hires all-female key leaders in Europe

European Pharmaceutical Review

She was medical lead at SIBAmed GmbH for four years. She has 20 years’ experience in business development and key account management in the clinical trials arena. About Velocity Clinical Research Velocity Clinical Research helps biopharmaceutical and CRO customers find the right patients for their studies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

7 commercial, sales, and marketing predictions for 2023

pharmaphorum

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”. Marketing data will surpass health data as a leading signal for pharma advertisers.

Marketing 101
article thumbnail

A matter of access

Star OUTiCO

I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up Key Account Management at Boehringer-Ingelheim. My career started as an RGN, and I continue to work in the NHS in renal medicine. Focus on Service-Redesign.

article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

Everything from training field personnel to navigate new tools more efficiently from remote environments, to changing both the offering and its customer platform (HCPs and patients) to create the highest level of value and impact will need renewed strategic attention. Leading Teams in the “New Normal” Environment.

article thumbnail

Transforming Oncology Outcomes Through Data & Digital

pharmaphorum

This disruption has changed the way doctors and cancer patients expect to experience services and products, and there is no going back now. Takeda Connect provides oncologists with information about their Key Account Manager and Medical Science Liaison, alongside direct access at the click of a button.

Doctors 57
article thumbnail

The Challenge of Growing Pharma Sales

Quantified

In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives. This requires them to interact more intensively to assess, engage, and maintain connections with HCPs and key decision-makers.

Sales 52